FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386004760> ?p ?o ?g. }

• W4386004760 abstract "Background/Hypothesis: Atogepant, an oral calcitonin gene-related peptide receptor antagonist, is approved for the preventive treatment of migraine in adults. This manuscript characterizes the safety, tolerability, pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of atogepant in healthy males. Methods: Data from two single-ascending dose phase 1 studies of atogepant were utilized to characterize pharmacokinetics and demonstrate proof of activity of atogepant in a capsaicin-induced dermal vasodilatation model and to determine the dosage(s) that results in 90% inhibition of capsaicin-induced dermal vasodilatation (effective concentration, EC 90 ) over 24 hours. Results: Single (0.4−200 mg) doses of atogepant were generally well tolerated by healthy participants with no treatment-related study discontinuations. Atogepant was rapidly absorbed with peak plasma concentrations occurring 1–2 hours post dose and a mean elimination half-life of ∼11 hours. Based on the capsaicin-induced dermal vasodilatation and pharmacokinetic/pharmacodynamic models, atogepant has an estimated EC 90 of 13.6 nM which was reached within 30 minutes at therapeutic doses and maintained for 24 hours at dosages of 60 mg once daily and 30 and 60 mg twice daily. Conclusion/Interpretation: Atogepant reached effective concentrations within 0.5 hours which were maintained for 24 hours at dosages of 60 mg once daily and 30 and 60 mg twice daily for the prevention of migraine. Trial Registration: Clinical Trial EudraCT Numbers: 2011-005020-18 (Study 1) and 2012-001192-36 (Study 2)." @default.
• W4386004760 created "2023-08-20" @default.
• W4386004760 creator A5014621784 @default.
• W4386004760 creator A5015491054 @default.
• W4386004760 creator A5027479348 @default.
• W4386004760 creator A5034116722 @default.
• W4386004760 creator A5040362663 @default.
• W4386004760 creator A5049035288 @default.
• W4386004760 creator A5060221986 @default.
• W4386004760 creator A5062480089 @default.
• W4386004760 creator A5079903461 @default.
• W4386004760 creator A5083730478 @default.
• W4386004760 creator A5089482349 @default.
• W4386004760 creator A5090607135 @default.
• W4386004760 date "2023-01-01" @default.
• W4386004760 modified "2023-10-12" @default.
• W4386004760 title "Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies" @default.
• W4386004760 cites W2005287183 @default.
• W4386004760 cites W2038399206 @default.
• W4386004760 cites W2058589230 @default.
• W4386004760 cites W2074769175 @default.
• W4386004760 cites W2075728979 @default.
• W4386004760 cites W2083276084 @default.
• W4386004760 cites W2087994192 @default.
• W4386004760 cites W2119392068 @default.
• W4386004760 cites W2129503049 @default.
• W4386004760 cites W2137924809 @default.
• W4386004760 cites W2152848856 @default.
• W4386004760 cites W2162942726 @default.
• W4386004760 cites W2166206304 @default.
• W4386004760 cites W2168198006 @default.
• W4386004760 cites W2623864543 @default.
• W4386004760 cites W2736411845 @default.
• W4386004760 cites W2766819558 @default.
• W4386004760 cites W2941010478 @default.
• W4386004760 cites W2976414363 @default.
• W4386004760 cites W3003253385 @default.
• W4386004760 cites W3016322114 @default.
• W4386004760 cites W3044272588 @default.
• W4386004760 cites W3050017463 @default.
• W4386004760 cites W3193766373 @default.
• W4386004760 doi "https://doi.org/10.1177/25158163231191582" @default.
• W4386004760 hasPublicationYear "2023" @default.
• W4386004760 type Work @default.
• W4386004760 citedByCount "0" @default.
• W4386004760 crossrefType "journal-article" @default.
• W4386004760 hasAuthorship W4386004760A5014621784 @default.
• W4386004760 hasAuthorship W4386004760A5015491054 @default.
• W4386004760 hasAuthorship W4386004760A5027479348 @default.
• W4386004760 hasAuthorship W4386004760A5034116722 @default.
• W4386004760 hasAuthorship W4386004760A5040362663 @default.
• W4386004760 hasAuthorship W4386004760A5049035288 @default.
• W4386004760 hasAuthorship W4386004760A5060221986 @default.
• W4386004760 hasAuthorship W4386004760A5062480089 @default.
• W4386004760 hasAuthorship W4386004760A5079903461 @default.
• W4386004760 hasAuthorship W4386004760A5083730478 @default.
• W4386004760 hasAuthorship W4386004760A5089482349 @default.
• W4386004760 hasAuthorship W4386004760A5090607135 @default.
• W4386004760 hasBestOaLocation W43860047601 @default.
• W4386004760 hasConcept C111113717 @default.
• W4386004760 hasConcept C112705442 @default.
• W4386004760 hasConcept C118303440 @default.
• W4386004760 hasConcept C126322002 @default.
• W4386004760 hasConcept C162156334 @default.
• W4386004760 hasConcept C163170386 @default.
• W4386004760 hasConcept C170493617 @default.
• W4386004760 hasConcept C197934379 @default.
• W4386004760 hasConcept C2778375690 @default.
• W4386004760 hasConcept C2778541695 @default.
• W4386004760 hasConcept C2780051329 @default.
• W4386004760 hasConcept C42219234 @default.
• W4386004760 hasConcept C71924100 @default.
• W4386004760 hasConcept C98274493 @default.
• W4386004760 hasConceptScore W4386004760C111113717 @default.
• W4386004760 hasConceptScore W4386004760C112705442 @default.
• W4386004760 hasConceptScore W4386004760C118303440 @default.
• W4386004760 hasConceptScore W4386004760C126322002 @default.
• W4386004760 hasConceptScore W4386004760C162156334 @default.
• W4386004760 hasConceptScore W4386004760C163170386 @default.
• W4386004760 hasConceptScore W4386004760C170493617 @default.
• W4386004760 hasConceptScore W4386004760C197934379 @default.
• W4386004760 hasConceptScore W4386004760C2778375690 @default.
• W4386004760 hasConceptScore W4386004760C2778541695 @default.
• W4386004760 hasConceptScore W4386004760C2780051329 @default.
• W4386004760 hasConceptScore W4386004760C42219234 @default.
• W4386004760 hasConceptScore W4386004760C71924100 @default.
• W4386004760 hasConceptScore W4386004760C98274493 @default.
• W4386004760 hasFunder F4320309117 @default.
• W4386004760 hasLocation W43860047601 @default.
• W4386004760 hasOpenAccess W4386004760 @default.
• W4386004760 hasPrimaryLocation W43860047601 @default.
• W4386004760 hasRelatedWork W1525173858 @default.
• W4386004760 hasRelatedWork W1925258783 @default.
• W4386004760 hasRelatedWork W1987721600 @default.
• W4386004760 hasRelatedWork W2072864465 @default.
• W4386004760 hasRelatedWork W2098591746 @default.
• W4386004760 hasRelatedWork W2214277799 @default.
• W4386004760 hasRelatedWork W2271392077 @default.
• W4386004760 hasRelatedWork W3208795098 @default.
• W4386004760 hasRelatedWork W4322617629 @default.

• next